Caterina Fumagalli

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Irritability in Bipolar Depression: Re-Examining a Neglected Dimension.

Irritability in Bipolar Depression: Re-Examining a Neglected Dimension.

Journal: Bipolar disorders

Published: October 13, 2025

Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Journal: Tumori

Published: July 10, 2025

Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ.

Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 10, 2024

Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review.

Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: December 22, 2023

Molecular testing in indeterminate thyroid nodules: an additional tool for clinical decision-making.

Molecular testing in indeterminate thyroid nodules: an additional tool for clinical decision-making.

Journal: Pathologica

Published: May 02, 2023

Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series.

Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series.

Journal: Cancers

Published: August 13, 2022

In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay.

In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay.

Journal: Pathologica

Published: July 19, 2022

A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer.

A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 22, 2022

Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive Patients.

Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive Patients.

Journal: Cancers

Published: February 09, 2022

Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.

Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.

Journal: Cancer research

Published: August 03, 2021

Breast Cancer Heterogeneity.

Breast Cancer Heterogeneity.

Journal: Diagnostics (Basel, Switzerland)

Published: July 20, 2021

Diagnostic and Predictive Biomarkers in Lung Cancer.

Diagnostic and Predictive Biomarkers in Lung Cancer.

Journal: Cancers

Published: May 19, 2021

Showing 1-12 of 49

Last Updated: 09/26/2026